Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II
AssigneeChildren's Hospital Los Angeles
InventorMargaret A. Schwarz
Life of this patent
Estimating the term…
Loading patent…
AssigneeChildren's Hospital Los Angeles
InventorMargaret A. Schwarz
Estimating the term…
A method of facilitating vascular growth in cardiac muscle of a subject in need of such treatment comprises inhibiting EMAP II activity in said subject by an amount effective to stimulate vascular growth in said cardiac muscle. The inhibiting step may be carried out by any suitable means, such as: By administering a compound (e.g., an antibody) that specifically binds to EMAP II to said subject in an amount effective to stimulate vascular growth in said cardiac muscle; by downregulating EMAP II expression in said subject by an amount effective to stimulate vascular growth in said cardiac muscle (e.g., by administration of an antisense olgionucleotide); or by administering an EMAP II receptor antagonist to said subject in an amount effective to stimulate vascular growth in said cardiac muscle.
A method of facilitating vascular growth in cardiac muscle of a subject in need of such treatment, comprising:
A method of facilitating vascular growth in cardiac muscle tissue of a subject in need of such treatment, said method comprising:
A composition comprising isolated recombinant EMAP II having a shelf life of at least 1 year under frozen conditions.
A pharmaceutical formulation comprising isolated recombinant EMAP II according in a sterile pharmaceutically acceptable carrier, and having a shelf life of at least 1 year under frozen conditions.
A method of making recombinant EMAP II, comprising the steps of:
A method of treating a brain tumor in a subject in need of such treatment, comprising administering EMAP II to said subject in an amount effective to treat said brain tumor.
Dependencies are inferred from the claim text.